9 CSR 30-3.032 - Certification of Substance Use Disorder Prevention and Treatment Programs

PURPOSE: This rule identifies the types of substance use disorder prevention and treatment programs and services eligible for certification from the department and the applicable requirements.

(1) Types of Programs and Services. Certification from the department is available for the following types of programs and services:

(A) Comprehensive Substance Treatment and Rehabilitation (CSTAR), including specialized programs for adolescents, women and children, adult general population, and opioid use disorders;

(B) Gambling disorder treatment;

(C) Institutional treatment center;

(D) Opioid treatment;

(E) Outpatient treatment;

(F) Prevention;

(G) Recovery support;

(H) Required Educational Assessment and Community Treatment (REACT);

(I) Residential treatment;

(J) Substance Awareness Traffic Offender Program (SATOP); and

(K) Withdrawal management.

(2) Applicable Program Regulations. The organization must comply with the regulations applicable to each program and/or service for which certification is being sought.

(3) Other Regulations. In addition to the regulations for specific programs and services as specified in 9 CSR 30-3, the organization must comply with other applicable regulations as follows:

(A) 9 CSR 10-7.010 to 9 CSR 10-7.140, Core Rules for Psychiatric and Substance Use Disorder Treatment Programs;

(B) 9 CSR 10-5.190 Background Screening Requirements;

(C) 9 CSR 10-5.200 Report of Complaints of Abuse, Neglect, and Misuse of Funds/Property;

(D) 9 CSR 10-5.206 Report of Events; and

(E) 9 CSR 10-5.220 Privacy Rule of Health Insurance Portability and Accountability Act of 1996 (HIPAA).

(4) Approval of Programs and Sites. The department must authorize and approve each proposed program/service and site prior to the delivery of services.

(A) Organizations requesting certification must comply with 9 CSR 10-7.130, Procedures to Obtain Certification, by submitting a fully completed application to the department.

(B) Notice of any change in program location, service array, or administration must be submitted to the department for approval prior to the change to ensure the program meets all applicable requirements, which may include an on-site review of the physical environment and safety practices.

(C) All opioid treatment programs shall meet the program and/or site approval requirements of this rule, as well as the requirements specified under 9 CSR 30-3.132.

Notes

9 CSR 30-3.032

AUTHORITY: sections 302.540, 630.050, 630.655, and 631.102, RSMo 2016.* 45 CFR parts 160 and 164, the Health Insurance Portability and Accountability Act of 1996. Original rule filed Feb. 28, 2001, effective Oct. 30, 2001. Amended: Filed March 8, 2002, effective Sept. 30, 2002. Emergency amendment filed April 1, 2003, effective April 14, 2003, expired Oct. 14, 2003. Amended: Filed April 1, 2003, effective Oct. 30, 2003. Amended: Filed May 28, 2021, effective Dec. 30, 2021.

AUTHORITY: sections 302.540, RSMo Supp. 2002 and 630.050, 630.655 and 631.102, RSMo 2000.* 45 CFR parts 160 and 164, the Health Insurance Portability and Accountability Act of 1996. Original rule filed Feb. 28, 2001, effective Oct. 30, 2001. Amended: Filed March 8, 2002, effective Sept. 30, 2002. Emergency amendment filed April 1, 2003, effective April 14, 2003, expired Oct. 14, 2003. Amended: Filed April 1, 2003, effective Oct. 30, 2003. Amended by Missouri Register November 1, 2021/Volume 46, Number 21, effective 12/31/2021